CIK 0001281895 · Non-accelerated filer<br>Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $405,500
- in 5 filings
Net −$405,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-18 | SOUTHWELL DAVID P Director | Grant or award | +22,862 | 54,522 | ||
| 2026-06-18 | SOUTHWELL DAVID P Director | Grant or award · Stock Option (Right to Buy) | +64,860 | 64,860 | ||
| 2026-06-18 | BOESS CARSTEN Director | Grant or award | +22,862 | 52,862 | ||
| 2026-06-18 | BOESS CARSTEN Director | Grant or award · Stock Option (Right to Buy) | +64,860 | 64,860 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −2,000 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −18,000 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −18,000 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −27,003 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −28,910 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −49,798 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Returned to the company · Stock Option (Right to Buy) | −24,545 | 0 | ||
| 2026-05-26 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +51,509 | 51,509 | ||
| 2026-05-26 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +15,002 | 15,002 | ||
| 2026-05-26 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +16,061 | 16,061 | ||
| 2026-05-26 | Militello John See Remarks | Grant or award · Stock Option (Right to Buy) | +24,899 | 24,899 |
Page 2 of 9 · 164 trades